Regeneron/Sanofi, Amgen PCSK9 Rivalry Continues, But Not In US Courts

Federal Circuit Affirms Invalidation Of Two Amgen Patents

 
• By Mandy Jackson
  
businessmen moving chess pieces on board of worldwide politics
Repatha and Praluent will continue to battle for US market share • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business